Article Details

GMP deficiencies disrupt production of ERC's cell-based vaccine

Retrieved on: 2021-05-03 09:00:00

Tags for this article:

Click the tags to see associated articles and topics

GMP deficiencies disrupt production of ERC's cell-based vaccine. View article details on hiswai:

Excerpt

When injected, the mixture stimulates the patient's immune system to mount an immune response against the tumor cells, which may lead to their ...

Article found on: bioprocessintl.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up